Immunotherapy (journal)
OCLC no. 495368971 | | |
| Links | ||
|---|---|---|
Immunotherapy is a
peer-reviewed medical journal covering immunology and more specifically immunotherapy. It was established in 2009 and is published by Future Medicine. The founding editor-in-chief
was Duc Hong Le. The current editors-in-chief are Y. Kawakami, F.M. Marincola, K. Tsang and D.C. Wraith.
Abstracting and indexing
The journal is abstracted and indexed in:
According to the Journal Citation Reports, the journal has a 2016 impact factor of 2.716, ranking it 90th out of 150 journals in the category "Immunology".[7]
References
- ^ "Biological Abstracts - Journal List". Intellectual Property & Science. Thomson Reuters. Archived from the original on 2016-01-01. Retrieved 2015-05-12.
- ^ a b "Master Journal List". Intellectual Property & Science. Thomson Reuters. Archived from the original on 2017-09-26. Retrieved 2014-12-13.
- ^ "CAS Source Index". Chemical Abstracts Service. American Chemical Society. Retrieved 2014-12-13.
- ^ "Journal titles covered in Embase". Embase. Elsevier. Retrieved 2015-05-12.
- ^ "Immunotherapy". NLM Catalog. National Center for Biotechnology Information. Retrieved 2014-12-13.
- ^ "Content overview". Scopus. Elsevier. Retrieved 2015-05-12.
- ^ "Journals Ranked by Impact: Immunology". 2016 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2017.